Microbiology Insights
Hunting contamination used to be a blind search. Biofluorescence monitoring lights it up in real time, seconds, not days, to spot it.
Simantini Singh Deo | Jul 28, 2026
The Silent Cascade : The visible event is a lagging indicator, but the causative shift came months earlier.
Dr. Varun Aggarwala | Jul 20, 2026
The Invisible Ecosystem: How Microbial Communities Inside Hospitals Shape Infection Risk
Mrudula Kulkarni | Jul 20, 2026
Modern Strategies For Mycoplasma Risk Management: The Silent Contaminant In Biopharmaceutical Manufacturing
Simantini Singh Deo | Jul 16, 2026
Other trending pieces on pharma manufacturing you may like to read
Biofluorescence Monitoring In Cleanrooms: A Simple Guide
Hunting contamination used to be a blind search. Biofluorescence monitoring lights it up in real time, seconds, not days, to spot it.
by Simantini Singh Deo
The Silent Cascade : The visible event is a lagging indicator, but the causative shift came months earlier.
One antibiotic course, two delayed symptoms, how silent gut disruption connects acne and vaginal infections months later.
by Dr. Varun Aggarwala
The Invisible Ecosystem: How Microbial Communities Inside Hospitals Shape Infection Risk
Hospitals aren't sterile, they're ecosystems. Microbial balance, not single pathogens, drives infection risk. See the 99% AMR-reduction trial data.
by Mrudula Kulkarni
Modern Strategies For Mycoplasma Risk Management: The Silent Contaminant In Biopharmaceutical Manufacturing
Mycoplasma is invisible to routine checks. Modern risk management combines prevention, rapid detection, and compliant response.
by Simantini Singh Deo
From Compliance to Contamination Control: How Annex 1 Is Reshaping Pharmaceutical Microbiology?
EU GMP Annex 1 made zero CFU the new Grade A standard. Here's how it's reshaping contamination control, EM programmes, and pharma microbiology.
by Simantini Singh Deo
